CHOKSILA
Choksi Laboratories financials
- Market cap
- ₹73 Cr
Quarterly results
Q1 FY27: revenue up 7.3%, net profit up 48.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9 | 10 | 11 | 11 | 11 +20% | 11 +4% | 13 +12% | 12 +7% |
| EBITDA | 2 | 3 | 4 | 3 | 3 +24% | 3 +5% | 4 +4% | 3 +13% |
| Net profit | 0 | 0 | 1 | 0 | 0 +200% | 0 +182% | 1 +12% | 1 +49% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −19.3% 1Y
1Y: ₹225.45 on 9 Sept 2025 → ₹182. High ₹225.45 (9 Sept 2025), low ₹89.65 (5 Mar 2026).
Financials, as filed
Revenue grew 11.9% a year over 2 years, FY24 to FY26. Operating margin narrowed to 26.4%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹37 Cr | ₹42 Cr | ₹46 Cr |
| Operating profit | ₹10 Cr | ₹11 Cr | ₹12 Cr |
| Operating margin | 28.0% | 26.9% | 26.4% |
| Interest | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| Depreciation | ₹6 Cr | ₹6 Cr | ₹7 Cr |
| Net profit | ₹1 Cr | ₹2 Cr | ₹2 Cr |
| Net margin | 3.0% | 3.7% | 4.3% |
| Cash from operations | ₹12 Cr | ₹12 Cr | ₹8 Cr |
| Free cash flow | ₹5 Cr | ₹4 Cr | ₹1 Cr |
| ROCE | 8.9% | 9.2% | 9.4% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr |
| Reserves | ₹11 Cr | ₹11 Cr | ₹14 Cr | ₹15 Cr | ₹18 Cr | ₹19 Cr |
| Borrowings | ₹39 Cr | ₹37 Cr | ₹32 Cr | ₹31 Cr | ₹29 Cr | ₹34 Cr |
| Other liabilities | ₹9 Cr | ₹9 Cr | ₹7 Cr | ₹9 Cr | ₹12 Cr | ₹12 Cr |
| Total liabilities | ₹66 Cr | ₹64 Cr | ₹60 Cr | ₹62 Cr | ₹65 Cr | ₹72 Cr |
| Fixed assets | ₹50 Cr | ₹47 Cr | ₹45 Cr | ₹43 Cr | ₹46 Cr | ₹52 Cr |
| Capital work in progress | ₹1 Cr | ₹2 Cr | ₹0 Cr | ₹3 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹16 Cr | ₹19 Cr | ₹20 Cr |
| Total assets | ₹66 Cr | ₹64 Cr | ₹60 Cr | ₹62 Cr | ₹65 Cr | ₹72 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, the public trimmed −2.73 pp while FIIs added +2.71 pp. The shareholder count shrank 5% to 3,945.
- Promoters
- 31.5%
- FIIs
- 7.0%
- Public
- 61.5%
Since Jun 2025
- Public −2.73 pp
- FIIs +2.71 pp
- Promoters 0.00 pp
How it drifted, 12 quarters
Over this window the public fell from 68.5% to 61.5% — −7.0 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 31.5%, Public 68.5%.Dec '23: Promoters 31.5%, Public 68.5%.Mar '24: Promoters 31.5%, Public 68.5%.Jun '24: Promoters 31.5%, Public 68.5%.Sep '24: Promoters 31.5%, Public 68.5%.Dec '24: Promoters 31.5%, Public 68.5%.Mar '25: Promoters 31.5%, FIIs 1.9%, Public 66.6%.Jun '25: Promoters 31.5%, FIIs 4.3%, Public 64.2%.Sep '25: Promoters 31.5%, FIIs 5.7%, Public 62.8%.Dec '25: Promoters 31.5%, FIIs 5.7%, Public 62.8%.Mar '26: Promoters 31.5%, FIIs 6.0%, Public 62.5%.Jun '26: Promoters 31.5%, FIIs 7.0%, Public 61.5%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Sunil Kumar Choksi - 2 +1.77 pp 7.51% held
- Nexus Global Opportunities Fund FPI fund +0.99 pp 7.02% held
The same filing shows 0 holders trimming and 2 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Choksi Laboratories Ltd. above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Sunil Kumar Choksi - 2 | 7.51% | +1.77 pp |
| Nexus Global Opportunities Fund FPI fund | 7.02% | +0.99 pp |
| Vyangesh Choksi | 6.42% | unchanged |
| Khyati Choksi | 4.33% | unchanged |
| Choksi Holding Company Private Limited | 4.31% | unchanged |
| Sachin Seth | 3.67% | unchanged |
| Stela Choksi | 3.16% | unchanged |
| Gaurav Anand | 2.87% | unchanged |
| Emkey Commercial Company Limited | 2.44% | unchanged |
| Asc Consulting Private Limited | 2.25% | unchanged |
| Timsy Kapoor | 2.15% | unchanged |
| Shantanu Trivedi | 2.15% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Choksi Laboratories Ltd.
Guides on how to read this kind of business and the numbers that matter.